Brief: IGC Filed A Patent Application With The U.S. Patent Office For A New Formulation To Treat Pain
July 21 (Reuters) - India Globalization Capital Inc IGC.A :
* IGC FILED A PATENT APPLICATION WITH THE U.S. PATENT OFFICE
FOR A
NEW FORMULATION TO TREAT PAIN
Source text for Eikon: ID:nBw5xxbHja
Further company coverage: IGC.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on IGC Pharma
See all newsFocus: Companies with cannabis-based drugs eye IPOs, private funding boost after US reclassification
Cannabis stocks climb after Trump signs order to ease curbs on marijuana (updated)
Cannabis stocks rise ahead of potential Trump order to ease marijuana restrictions
Brief: IGC Pharma's Unit Enters Sale Of Assets Agreement For $2.7 Million - SEC Filing
Brief: IGC Pharma Announces Additional Phase 2 Interim Results Highlighting Cognitive Benefits of IGC-AD1 for Alzheimer's Treatment